(Total Views: 275)
Posted On: 12/07/2020 11:05:47 AM
Post# of 44

$AFMD News Article - Affimed Announces Updated AFM13 Clinical Data Presentation at the American Society of Hematology Annual Meeting, Demonstrating Good Tolerability and a High Objective Response Rate in Patients with Recurrent/Refractory CD30-positive Lymphoma https://marketwirenews.com/news-releases/affi...15088.html


My Twitter: WhyteStocks